AVITA Medical, Inc.
RCEL
$7.51
-$0.30-3.84%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -5.83% | 28.63% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -5.83% | 28.63% | |||
Cost of Revenue | -28.53% | 51.11% | |||
Gross Profit | -1.41% | 25.01% | |||
SG&A Expenses | -14.15% | 3.92% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -14.96% | 8.29% | |||
Operating Income | 27.88% | 11.52% | |||
Income Before Tax | 28.73% | -5.68% | |||
Income Tax Expenses | 167.86% | -184.85% | |||
Earnings from Continuing Operations | 28.49% | -5.28% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 28.49% | -5.28% | |||
EBIT | 27.88% | 11.52% | |||
EBITDA | 29.25% | 12.36% | |||
EPS Basic | 28.94% | -4.38% | |||
Normalized Basic EPS | 23.85% | 1.56% | |||
EPS Diluted | 28.94% | -4.38% | |||
Normalized Diluted EPS | 23.85% | 1.56% | |||
Average Basic Shares Outstanding | 0.62% | 0.87% | |||
Average Diluted Shares Outstanding | 0.62% | 0.87% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |